Metabolic effects of a novel silicate inositol complex of the nitric oxide precursor arginine in the obese insulin-resistant JCR:LA-cp rat
Authors:
- Spencer D. ProctorSPSpencer D. Proctor
- Sandra E. KellySKSandra E. Kelly
- Donna F. VineDVDonna F. Vine
- James C. RussellJRJames C. Russell
- 1 October 2007
- journal article
- Published by Elsevier in Metabolism
- Vol. 56 (10) , 1318-1325
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The metabolic syndrome in polycystic ovary syndromeJournal of Endocrinological Investigation, 2006
- Development of polycystic ovary syndrome: involvement of genetic and environmental factorsInternational Journal of Andrology, 2006
- A novel complex of arginine–silicate improves micro- and macrovascular function and inhibits glomerular sclerosis in insulin-resistant JCR:LA-cp ratsDiabetologia, 2005
- L-Arginine and AtherothrombosisThe Journal of Nutrition, 2004
- Arginine and Endothelial and Vascular HealthThe Journal of Nutrition, 2004
- Session III: Arginine and Pathophysiology I—Discussion SummaryThe Journal of Nutrition, 2004
- Effects of LY117018 and the Estrogen Analogue, 17α-Ethinylestradiol, on Vascular Reactivity, Platelet Aggregation, and Lipid Metabolism in the Insulin-Resistant JCR:LA-cp Male Rat: Role of Nitric OxideJournal of Cardiovascular Pharmacology, 2001
- Hyperinsulinemia as an Independent Risk Factor for Ischemic Heart DiseaseNew England Journal of Medicine, 1996
- Nitric oxide— biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosisAtherosclerosis, 1995
- 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.Circulation, 1990